Publications by authors named "Jacob Allred"

Claim this Profile
P
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.
Dan P Zandberg, Jacob B Allred, Ari J Rosenberg, John M Kaczmar, Paul Swiecicki

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors.
Aurora Norman, Mahesh Seetharam, Jacob Allred, Jianping Kong, Mateusz Opyrchal

BJC Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Computational and Spectroscopic Analysis of Solvate Ionic Liquids Containing Anions with Long and Short Perfluorinated Alkyl Chains.
Karina Shimizu, Adilson Alves de Freitas, Jacob T Allred, Christopher M Burba

Molecules· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of sequences of the CDK4/6 Inhibitor, Ribociclib Combined with Gemcitabine in Patients with Advanced Solid Tumors.
Mahesh Seetharam, Aurora Norman, Jacob Allred, Jianping Kong, Mateusz Opyrchal

Res Sq· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Katherine E R Smith, Kah-Whye Peng, Jose S Pulido, Adam J Weisbrod, Carrie A Strand, Jacob B Allred

Front Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
Matthew Ingham, Jacob B Allred, Li Chen, Biswasjit Das, Bose Kochupurakkal

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
James W Jakub, Michael Lowe, J Harrison Howard, Jeffrey M Farma, Amod Sarnaik, Jacob B Allred

Ann Surg Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance).
Jessica A Slostad, Minetta C Liu, Jacob B Allred, Lori A Erickson, Kandelaria M Rumilla

Mayo Clin Proc Innov Qual Outcomes· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.
Riyue Bao, Oliver Surriga, Daniel J Olson, Jacob B Allred, Carrie A Strand

Melanoma Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
Matthew S Block, Allan B Dietz, Michael P Gustafson, Kimberly R Kalli, Courtney L Erskine, Jacob B Allred

Nat Commun· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanoma.
Eric P Grewal, Courtney L Erskine, Wendy K Nevala, Jacob B Allred, Carrie A Strand

Immunotherapy· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination.
Ryan M Carr, Narjust Duma, Angela L McCleary-Wheeler, Luciana L Almada, David L Marks, Jacob B Allred

Pancreatology· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201).
Jason J Luke, Daniel J Olson, Jacob B Allred, Carrie A Strand, Riyue Bao

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Angela L McCleary-Wheeler, Ryan M Carr, Shanique R Palmer, Thomas C Smyrk, Jacob B Allred

Pancreatology· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1.
Matthew S Block, Wendy K Nevala, Yuan-Ping Pang, Jacob B Allred, Carrie Strand

Melanoma Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
Arti Hurria, Enrique Soto-Perez-de-Celis, Jacob B Allred, Harvey Jay Cohen, Anait Arsenyan

J Am Geriatr Soc· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.
Myra Barginear, Amylou C Dueck, Jacob B Allred, Craig Bunnell, Harvey J Cohen

Oncologist· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors.
Khalid Jazieh, Julian Molina, Jacob Allred, Jun Yin, Joel Reid

Invest New Drugs· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance).
Jesus Vera Aguilera, Ravi D Rao, Jacob B Allred, Vera J Suman, Harold E Windschitl

Oncologist· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
Robert R McWilliams, Jacob B Allred, Jessica A Slostad, Rajini Katipamula, Roxana S Dronca

Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
Roberto A Leon-Ferre, Lisa A Kottschade, Matthew S Block, Robert R McWilliams, Roxana S Dronca, Jacob B Allred

Melanoma Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.
James W Jakub, Alicia M Terando, Amod Sarnaik, Charlotte E Ariyan, Mark B Faries, Jacob B Jake Allred

Ann Surg· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.
Jarrett J Failing, Heidi D Finnes, Lisa A Kottschade, Jacob B Allred, Svetomir N Markovic

Melanoma Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma.
William G Rule, Jacob B Allred, Barbara A Pockaj, Svetomir N Markovic, David J DiCaudo

Cancer Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients.
Winston W Tan, Jacob B Allred, Alvaro Moreno-Aspitia, Donald W Northfelt, James N Ingle

Clin Breast Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis